The Ensign Group Stock EBITDA
EGB Stock | EUR 130.00 1.00 0.76% |
The Ensign Group fundamentals help investors to digest information that contributes to Ensign's financial success or failures. It also enables traders to predict the movement of Ensign Stock. The fundamental analysis module provides a way to measure Ensign's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ensign stock.
Ensign |
The Ensign Group Company EBITDA Analysis
Ensign's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Ensign EBITDA | 360.38 M |
Most of Ensign's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Ensign Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
According to the company disclosure, The Ensign Group reported earnings before interest,tax, depreciation and amortization of 360.38 M. This is 58.93% lower than that of the Healthcare sector and 231.02% higher than that of the Long-Term Care Facilities industry. The ebitda for all Germany stocks is 90.76% higher than that of the company.
Ensign EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ensign's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ensign could also be used in its relative valuation, which is a method of valuing Ensign by comparing valuation metrics of similar companies.Ensign is currently under evaluation in ebitda category among its peers.
Ensign Fundamentals
Return On Equity | 0.2 | |||
Return On Asset | 0.0589 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.1 % | |||
Current Valuation | 5.87 B | |||
Shares Outstanding | 55.73 M | |||
Shares Owned By Insiders | 3.77 % | |||
Shares Owned By Institutions | 93.78 % | |||
Price To Earning | 30.36 X | |||
Price To Book | 4.34 X | |||
Price To Sales | 1.74 X | |||
Revenue | 3.03 B | |||
Gross Profit | 534.92 M | |||
EBITDA | 360.38 M | |||
Net Income | 224.68 M | |||
Cash And Equivalents | 41.86 M | |||
Cash Per Share | 0.79 X | |||
Total Debt | 149.27 M | |||
Debt To Equity | 197.20 % | |||
Current Ratio | 1.15 X | |||
Book Value Per Share | 22.61 X | |||
Cash Flow From Operations | 272.51 M | |||
Earnings Per Share | 3.73 X | |||
Price To Earnings To Growth | 1.33 X | |||
Target Price | 96.8 | |||
Number Of Employees | 29.9 K | |||
Beta | 0.95 | |||
Market Capitalization | 4.65 B | |||
Total Asset | 3.45 B | |||
Z Score | 18.6 | |||
Annual Yield | 0 % | |||
Five Year Return | 0.62 % | |||
Net Asset | 3.45 B | |||
Last Dividend Paid | 0.22 |
About Ensign Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Ensign Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ensign using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Ensign Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
OEF | iShares SP 100 | |
GLD | SPDR Gold Shares | |
OIH | VanEck Oil Services | |
IBB | iShares Biotechnology ETF | |
IJH | iShares Core SP |
Additional Information and Resources on Investing in Ensign Stock
When determining whether Ensign Group is a strong investment it is important to analyze Ensign's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ensign's future performance. For an informed investment choice regarding Ensign Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in The Ensign Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.